Publications by authors named "Guohuan Yang"

Background: The response of hepatocellular carcinoma (HCC) to transarterial chemoembolization (TACE) treatment and its underlying mechanisms remain elusive. This study investigates the role of enzymes involved in fatty acid activation, specifically Acyl-CoA synthetase long chain 4 (ACSL4), in HCC patients treated with postoperative adjuvant TACE (PA-TACE) and in nutrient-deprived HCC cells.

Methods: We examined the expression of ACSL4 and its family members in HCC clinical samples and cell lines.

View Article and Find Full Text PDF
Article Synopsis
  • Single-cell technology offers a more comprehensive view of tumors by analyzing both tumor cells and their surrounding microenvironments, potentially improving diagnosis compared to traditional methods that focus solely on pathology.
  • Despite its advantages, single-cell RNA sequencing (scRNA-seq) faces significant issues, including complex data structures and low signal clarity, which hinder its diagnostic use.
  • The authors introduce a graph neural network framework designed for diagnosing primary liver tumors by leveraging scRNA-seq data and intercellular communication networks, demonstrating accurate differentiation between malignant and benign tumors and validating their findings with public datasets.
View Article and Find Full Text PDF
Article Synopsis
  • Scientists studied ribosomal RNA (rRNA) in human skin cells to learn how it changes when cells stop growing or are affected by stress.
  • They found that different patterns of a chemical change called 2'-O-methylation (2'-O-Me) in rRNA are linked to how the cells behave when they are stopped from growing.
  • By tweaking certain RNAs that help with these changes, they discovered they could either help the cells grow more or make them stop growing, showing that rRNA modifications can affect how cells develop.
View Article and Find Full Text PDF
Article Synopsis
  • Intratumoral immune status plays a crucial role in how patients with intrahepatic cholangiocarcinoma respond to therapy, especially with a combination of gemcitabine, oxaliplatin, lenvatinib, and anti-PD1 antibody.
  • High levels of certain CD8 T-cell markers (GZMB and proliferating CD8) and low levels of Macro CD5L predict better therapeutic responses, while shifts in T-cell markers indicate varying response levels.
  • The study also suggests that using anti-CTLA4 antibody can counteract therapy resistance caused by immune exhaustion, paving the way for more effective cancer treatments based on immune profiling.
View Article and Find Full Text PDF

Background: Minimal residual disease (MRD) is proposed to be responsible for tumor recurrence. The role of circulating tumor DNA (ctDNA) to detect MRD, monitor recurrence, and predict prognosis in liver cancer patients undergoing liver transplantation (LT) remains unrevealed.

Methods: Serial blood samples were collected to profile ctDNA mutational changes.

View Article and Find Full Text PDF

RNA vaccines, including conventional messenger RNA (mRNA) vaccines, circular RNA (circRNA) vaccines, and self-amplifying RNA (saRNA) vaccines, have ushered in a promising future and revolutionized vaccine development. The success of mRNA vaccines in combating the COVID-19 pandemic caused by the SARS-CoV-2 virus that emerged in 2019 has highlighted the potential of RNA vaccines. These vaccines possess several advantages, such as high efficacy, adaptability, simplicity in antigen design, and the ability to induce both humoral and cellular immunity.

View Article and Find Full Text PDF

Traumatic brain injury (TBI) is a prevalent neurological disorder and a leading cause of death and disability worldwide. The high mortality rates result in a tremendous burden on society and families in terms of public health and economic costs. Despite advances in biomedical research, treatment options for TBI still remain limited, and there is no effective therapy to restore the structure and function of the injured brain.

View Article and Find Full Text PDF
Article Synopsis
  • Advanced intrahepatic cholangiocarcinoma (ICC) has poor outcomes, but a new combination therapy of toripalimab, lenvatinib, and GEMOX shows promise as a first-line treatment.
  • In a study of 30 patients, the therapy resulted in an 80% objective response rate, with most experiencing either partial or complete responses, and an overall disease control rate of 93.3%.
  • While manageable adverse events occurred in over half of the patients, including neutropenia and leukocytopenia, the overall survival and progression-free survival were encouraging, prompting further validation in a larger clinical trial.
View Article and Find Full Text PDF

The coronavirus SARS-CoV-2 has mutated quickly and caused significant global damage. This study characterizes two mRNA vaccines ZSVG-02 (Delta) and ZSVG-02-O (Omicron BA.1), and associating heterologous prime-boost strategy following the prime of a most widely administrated inactivated whole-virus vaccine (BBIBP-CorV).

View Article and Find Full Text PDF
Article Synopsis
  • * Lower levels of 5-hydroxymethylcytosine (5-hmC) in HCC tissues are associated with worse cancer characteristics and resistance to chemotherapy after liver transplantation.
  • * The enzyme TET2 regulates 5-hmC levels, and its reduction leads to chemotherapy resistance via inhibition of PCAF and hyperactivation of AKT signaling, making it a potential target for improving treatment outcomes.
View Article and Find Full Text PDF

Objective: Intrahepatic cholangiocarcinoma (iCCA) is a primary liver malignancy with a poor prognosis and limited treatment. Cisplatin with gemcitabine is used as the standard first-line chemotherapy regimen; however, there is still no robust evidence for second-line and successive treatments. Although preliminary evidence suggests a vital role of precision therapy or immunotherapy in a subset of patients, the gene alteration rate is relatively low.

View Article and Find Full Text PDF

Objective: This study evaluated the antitumor activity and safety of pemigatinib in previously treated Chinese patients with advanced cholangiocarcinoma and fibroblast growth factor receptor 2 (FGFR2) fusions or rearrangements.

Background: Pemigatinib provided clinical benefits for previously treated patients with cholangiocarcinoma carrying FGFR2 fusions or rearrangements and was approved for this indication in multiple countries.

Methods: In this ongoing, multicenter, single-arm, phase II study, adult patients with locally advanced or metastatic cholangiocarcinoma carrying centrally confirmed FGFR2 fusions or rearrangements who had progressed on ≥1 systemic therapy received 13.

View Article and Find Full Text PDF

The association between high-dose or low-dose sodium-glucose cotransporter 2 (SGLT2) inhibitors and various cardiovascular and respiratory serious adverse events (SAE) is unclear. Our meta-analysis aimed to define the association between high-dose or low-dose SGLT2 inhibitors and 86 kinds of cardiovascular SAE and 58 kinds of respiratory SAE. We included large cardiorenal outcome trials of SGLT2 inhibitors.

View Article and Find Full Text PDF

Purpose: To uncover the biological role of LINC00355 in regulating the proliferative and apoptotic potentials in hepatocellular carcinoma (HCC), and the underlying mechanism.

Methods: LINC00355 levels in HCC tissues and cell lines were detected by quantitative real-time polymerase chain reaction (qRT-PCR). After knockdown of LINC00355 or miR-217-5p in Hub7 and Hep3B cells, proliferative and apoptotic potentials were assessed by cell counting kit-8 (CCK-8), colony formation assay and flow cytometry.

View Article and Find Full Text PDF

This study aimed to evaluate the role of plasma microRNA panel (miR-122, miR-192, miR-21, miR-223, miR-26a, miR-27a and miR-801) for prediction and surveillance of early tumor recurrence in hepatocellular carcinoma (HCC) patients who had undergone liver transplantation (LT). The expression of plasma microRNA panel was assayed in 193 HCC patients (training cohort, n =151; validation cohort, n = 42). Sensitivity and specificity for detecting post-transplant HCC recurrence, and the relationship of microRNA panel expression with clinical characteristics were analyzed accordingly.

View Article and Find Full Text PDF

Intrahepatic cholangiocarcinoma (ICC) is highly invasive and carries high mortality due to limited therapeutic strategies. In other solid tumors, immune checkpoint inhibitors (ICIs) target cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and programmed death 1 (PD1), and the PD1 ligand PD-L1 has revolutionized treatment and improved outcomes. However, the relationship and clinical significance of CTLA-4 and PD-L1 expression in ICC remains to be addressed.

View Article and Find Full Text PDF

To elucidate the trophic pathways and bioaccumulation characteristics of heavy metals in marine fish, 20 Sardinella albella specimens of different lengths were collected from Liusha Bay in Beibu Gulf of South China Sea and aimed to study their trophic level and heavy metal pollution. The results showed that their δC values ranged from -17.61 to -15.

View Article and Find Full Text PDF

The grain-size distributions and heavy metal content in two sediment cores from Dachan Bay were analyzed, and the vertical distribution, provenance, and ecological risk of heavy metal were evaluated. The concentrations (μg g) of Cu, Pb, Zn, Cd, Cr, Hg, As, and Ni in the sediment samples were 14.8-408, 33.

View Article and Find Full Text PDF

The survival of patients with hepatocellular carcinoma (HCC) recurrence after curative resection is usually poor. We sought to evaluate the safety and efficacy of adjuvant transarterial chemoembolization (TACE) in HBV-related HCC patients with an intermediate (a single tumor larger than 5 cm without microvascular invasion) or high risk (a single tumor with microvascular invasion, or two or three tumors) of recurrence. In this randomized phase 3 trial, 280 eligible patients were assigned to adjuvant TACE ( = 140) or no adjuvant treatment (control; = 140) groups.

View Article and Find Full Text PDF

The Gac/Rsm regulatory pathway in Pseudomonas spp. activates the production of various secondary metabolites, such as antibiotics, siderophores and exoenzymes. However, the biosynthesis of antifungal compound pyoluteorin (Plt) in Pseudomonas protegens H78 is almost entirely inhibited by double deletion of two csrA/rsmA family genes, namely, rsmA and rsmE.

View Article and Find Full Text PDF

Calpain small subunit 1 (Capn4) has been identified as a major gene that promotes metastasis of hepatocellular carcinoma (HCC). However, the mechanism by which Capn4 promotes progression of HCC is not understood. In this study, we found that Capn4 expression was increased in highly metastatic HCC cell lines and in tumour tissue from HCC patients compared to healthy patient tissue.

View Article and Find Full Text PDF

Hepatocellular carcinoma (HCC) is one of the most serious health problems worldwide. As in many other diseases, environment and genetic factors are believed to be involved in the pathogenesis of HCC. Numerous epidemiologic investigations including case-control and cohort studies have suggested the association of glutathione S-transferase (GST) genetic polymorphisms and HCC risk.

View Article and Find Full Text PDF

CXCL5 is a member of the CXC-type chemokine family that may play a role in carcinogenesis and cancer progression. This study investigates the biological function and clinical significance of CXCL5 in intrahepatic cholangiocarcinoma (ICC). We demonstrated that CXCL5 was overexpressed in ICC cell lines and tumor samples compared with paired normal tissues.

View Article and Find Full Text PDF